BRD9 and hepatocellular carcinoma: Similar findings have been reported in hepatocellular carcinoma (HCC), with BRD9 overexpressed in HCC patients as well as promoting cell growth and metastasis, and its depletion and inhibition reducing these effects in HCC cells [36].